Acadia Pharmaceuticals | ACAD - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 0.13 0.42 Nov/11
FY2026Q2 Jun/2026 0.18 0.06 0.16 Aug/04
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
ALKERMES USD 0 0.4 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Cara Therapeutics USD -0.72 0.14 2026-03
Corcept Therapeutics USD 0.36 0.66 2026-06
Cytokinetics USD -1.67 0.17 2026-03
Eisai JPY 64.71 76.24 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Incyte USD 3.09 1.28 2026-06
J&J USD 2.9 0.2 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Pfizer USD 0.77 0.02 2026-06
Prothena USD 0.6 1.06 2026-03
PTC Therapeutics USD 0.92 0.95 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vanda Pharmaceuticals USD -0.09 0 2024-12
Vertex Pharmaceuticals USD 4.73 0.26 2026-06